Finally, we introduced a novel protein target, FABP3, in nicotine-induced addiction, and elucidated the underlying mechanisms of the failed process in nicotine-induced addiction, demonstrating that FABP3 is an anticipated therapeutic target in nicotine addiction and other drugs of abuse affecting DAergic systems. The gene discussed is FABP3; the disease is nicotine dependence.